Stay updated on Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T03:50:58.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    An NIH announcement banner about a website transition appears above the ClinicalTrials.gov 403 error page.
    Difference
    1%
    Check dated 2026-10-25T04:13:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T03:52:32.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T04:46:39.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page remains on a 403 Forbidden error screen, with no study details displayed.
    Difference
    0.2%
    Check dated 2026-10-04T08:14:58.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page with a minimal HTML header and a Home link, indicating restricted access. The detailed study content and related navigation previously visible on the page have been removed.
    Difference
    22%
    Check dated 2026-09-20T02:07:41.000Z thumbnail image

Stay in the know with updates to Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.